| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_52a24331fe7882d8a0801155df05d542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7744a9d4db8535cd73f6508526b517ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd2000ff3185b074dbbf097799c822c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37fd0df655b683d8db7367c7de8047a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e80b143287acbbc81e587ca370dacf92 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2330-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1131 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-51 |
| filingDate |
2006-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a12ec1e51985bf841a7db3f4bf529331
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6c8e14098a782ca7520cc742238e596
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81deb411ab4b3bc96fb8922420d03bb6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6937dc373d5980b6b5eb5098d5ec381e |
| publicationDate |
2006-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006096018-A1 |
| titleOfInvention |
Small interfering rna and pharmaceutical composition for treatment of hepatitis b comprising the same |
| abstract |
The present invention relates to RNA interference mediated inhibition of Hepatitis B virus (HBV) by short interfering RNA (siRNA) molecules. Specially, siRNAs of the present invention which are double-stranded RNAs concern directing the sequence-specific degradation of viral RNA in mammalian cells. Disclosed is a DNA vector encoding the RNA molecules and synthesized siRNA molecules as well as method of therapeutic treatment for inhibition of HBV gene expression and viral replication by the administration of RNA molecules of the present invention. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102167524-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11414665-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019105435-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11492620-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11633482-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2308514-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11517584-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190111147-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016074626-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3315608-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020038377-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104059917-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11660347-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE48345-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11534453-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111020024-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102140460-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11590156-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009038266-A1 |
| priorityDate |
2005-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |